Fannie Mae, Freddie Mac shares tumble after conservatorship comments
Karen McLoughlin, a director at agilon health, inc. (NYSE:AGL), recently acquired 25,000 shares of the company's common stock. The timing is notable as the stock has declined over 82% year-to-date, though it has shown strength with positive returns in the past month. The shares were purchased at a weighted average price of $2.2034, with transactions occurring between $2.175 and $2.215. This acquisition amounts to a total value of $55,084. Following this transaction, McLoughlin holds a total of 73,166 shares, which includes restricted stock units. According to InvestingPro analysis, agilon health appears undervalued at its current market cap of $915 million, with 12 additional exclusive insights available to subscribers, including detailed valuation metrics and financial health indicators.
In other recent news, Agilon Health has experienced several significant developments. Bernstein SocGen Group initiated coverage of the company with a Market Perform rating, while Jefferies and TD Cowen reduced their price targets. JMP Securities downgraded the stock rating following a third-quarter earnings miss. Agilon Health reported a 28% increase in revenue year-over-year, reaching $1.45 billion, but fell short of the projected $1.47 billion. The company also experienced an adjusted EBITDA loss of $96 million.
Additionally, Agilon Health updated indemnification agreements and relocated its headquarters to Westerville, Ohio. Despite financial challenges, the company reported a 37% year-over-year growth in Medicare Advantage membership and raised its full-year membership guidance. However, Agilon Health revised its full-year 2024 adjusted EBITDA guidance downward, indicating potential financial challenges ahead. These are recent developments that investors may wish to consider.
This article was generated with the support of AI and reviewed by an editor. For more information see our T&C.